- Total Net Revenue ("Revenue") was $175.2 million, an increase of 9.2% from $160.5 million in the third quarter of 2013
- Adjusted EBITDA(1) was $25.4 million, a decrease of 11.3% from $28.6 million in the prior year's third quarter
- RadNet reports diluted per share Net Loss of $0.01 compared to diluted per share Net Income of $0.06 in the prior year's third quarter, adjusting for a $0.07 gain from the de-consolidation of a joint venture in 2012
- While same center procedural volumes were flat as compared with the third quarter of 2012, same center revenue declined 3.6% over the same period last year
- RadNet announces an initiative to save up to $30 million in operating costs to address industry pressures of declining utilization and pricing
- RadNet revises its 2013 guidance levels to be consistent with year to date actual performance
LOS ANGELES, Nov. 11, 2013 (GLOBE NEWSWIRE) -- RadNet, Inc. (Nasdaq:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 251 owned and/or operated outpatient imaging centers, today reported financial results for its third quarter of 2013.
Third Quarter Financial Results
For the third quarter of 2013, RadNet reported Revenue, Adjusted EBITDA(1) and Net Loss Attributable to RadNet, Inc. Common Stockholders ("Net Loss") of $175.2 million, $25.4 million and $(467,000), respectively. Revenue increased $14.7 million (or 9.2%), Adjusted EBITDA(1) decreased $3.2 million (or 11.3%) and Net Income decreased $2.7 million (adjusting for the $2.8 million gain in the third quarter of 2012 from the deconsolidation of a joint venture), respectively, over the third quarter of 2012. Net Loss for the third quarter was $(0.01) per diluted share, compared to a Net Income of $0.06 per diluted share in the third quarter of 2012 (again adjusting for the gain from the deconsolidation of the joint venture). These per share values are based upon a weighted average number of diluted shares outstanding of 39.2 million and 39.9 million for these periods in 2013 and 2012, respectively.
Affecting operating results in the third quarter of 2013 were certain non-cash expenses and non-recurring items including: $463,000 of non-cash employee stock compensation expense resulting from the vesting of certain options and restricted stock; $72,000 of severance paid in connection with headcount reductions related to cost savings initiatives from previously announced acquisitions; $5,000 gain on the disposal of certain capital equipment; and $1.2 million of non-cash amortization of deferred loan costs and discount on issuance of debt as part of our existing credit facilities.
For the third quarter of 2013, as compared to the prior year's third quarter, MRI volume increased 12.7%, CT volume increased 3.7% and PET/CT volume decreased 0.3%. Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 12.0% over the prior year's third quarter. On a same-center basis, including only those centers which were part of RadNet for both the third quarters of 2013 and 2012, MRI volume decreased 2.2%, CT volume increased 1.6% and PET/CT volume increased 1.8%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, was flat over the prior year's same quarter.
Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented "We have been experiencing pressured reimbursement and lower than anticipated utilization all year. The lower utilization and pricing of imaging services has not been unique to RadNet and has been an industry-wide phenomenon in the outpatient, free-standing marketplace during 2013."
"In response to the combination of pricing and utilization declines, we have worked hard to create and begin executing a cost savings program targeted at saving $30 million of annual operating costs. Some of the initiatives comprising this plan have been implemented during the third quarter or will be implemented by year-end, which will provide us with a full-year's impact of their benefits in 2014. Other initiatives will be implemented during 2014. Areas of savings include elimination of salaries and personnel, savings from Information Technology implementations (including our continued migration to eRAD RIS and PACS and voice recognition transcription), certain supplies and purchasing programs and corporate savings from changes to our workers compensation, healthcare and property and casualty insurance, commercial banking fees and physician compensation."
"These cuts are the result of our continual efforts to mitigate industry pressures. Unfortunately, we were unable to affect some of these programs in the last three quarters, which resulted in our performance lagging behind our expectations. Our focus is for these initiatives to outpace the continuing pressures in 2014, so that 2014 will show, in addition to continued aggregate revenue growth, improvements in EBITDA and profitability. I'm further encouraged by very strong volumes we have experienced in the fourth quarter so far, relative to last year's same period," added Dr. Berger.
Nine Month Financial Results
For the nine months ended September 30, 2013, RadNet reported Revenue, Adjusted EBITDA(1) and Net Income of $524.6 million, $81.0 million and $877,000, respectively. Revenue increased $36.8 million (or 7.6%), Adjusted EBITDA(1) decreased $8.1 million (or 9.1%) and Net Income decreased $4.2 million (adjusting for the $2.8 million gain in the third quarter of 2012 from the deconsolidation of a joint venture), respectively, over the first nine months of 2012. Net Income for the nine month period ended September 30, 2013 was $0.02 per diluted share, compared to Net Income of $0.13 per diluted share in corresponding nine month period of 2012 (again adjusting for the gain from the deconsolidation of the joint venture). These per share values are based upon a weighted average number of fully diluted shares outstanding of 39.9 million and 39.2 million for these periods in 2013 and 2012, respectively.
Affecting operating results in the nine months ended September 30, 2013 were certain non-cash expenses and non-recurring items including: $2.0 million of non-cash employee stock compensation expense resulting from the vesting of certain options and restricted stock; $312,000 of severance paid in connection with headcount reductions related to cost savings initiatives from previously announced acquisitions; $357,000 loss on the disposal of certain capital equipment; and $3.3 million of non-cash amortization of deferred loan costs and discount on issuance of debt as part of our existing credit facilities.
RadNet has revised its previously announced 2013 fiscal year guidance ranges:
|Original Guidance Level||Revised Guidance Level|
|Guidance Revenue (a)||$700 million - $730 million||$700 million - $730 million|
|Adjusted EBITDA(1)||$120 million - $130 million||$105 million - $110 million|
|Capital Expenditures (b)||$35 million - $40 million||$35 million - $40 million|
|Cash Interest Expense||$42 million - $47 million||$40 million - $43 million|
|Free Cash Flow Generation (c)||$35 million - $45 million||$20 million - $30 million|
|(a) Service Fee Revenue, net of contractual allowances plus Revenue under capitation arrangements.|
|(b) Net of proceeds from the sale of equipment, imaging centers and joint venture interests.|
|(c) Defined by the Company as Adjusted EBITDA(1) less total capital expenditures and cash paid for interest.|
Dr. Berger added, "The challenges we've experienced in our same center revenue performance has caused us to revise downward our Adjusted EBITDA projections and Free Cash Flow Generation guidance levels for 2013. While I'm confident that the costs savings plans we are implementing will help mitigate in 2014 the challenging utilization and pricing environment, the effects of these challenges have impacted our same center performance this year."
"Aside from operational changes and cost reductions, we continue to pursue opportunities to lower our cost of capital. This includes evaluating refinancing plans for our 10 3/8% senior unsecured notes, which become callable in April of next year. Lowering our interest expense will allow us to have more cash flow to deleverage our balance sheet through debt paydown or expand our EBITDA through acquisitions and investments that we would otherwise fund through future borrowings. We anticipate building a cash balance at the end of 2013 of between $5 million and $10 million. This is the result of expected incremental free cash flow in the fourth quarter resulting from having front-loaded the vast majority of our capital expenditures in the first three quarters of 2013."
Conference Call for Today
Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss RadNet's third quarter 2013 results on Monday, November 11th, 2013 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Daylight Time).
|Conference Call Details:|
|Date: Monday, November 11, 2013|
|Time: 10:30 a.m. Eastern Time|
|Dial In-Number: 888-430-8705|
|International Dial-In Number: 719-457-2648|
It is recommended that participants dial in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. An archived replay of the call will also be available and can be accessed by dialing 877-870-5176 from the U.S., or 858-384-5517 for international callers, and using the passcode 8290270.
There will also be a simultaneous live webcast of the conference call which can be accessed under "News" in the RadNet Investor Relations section of the company website at http://www.radnet.com/ or you may use the link audio feed and archived recording of the conference call available at http://public.viavid.com/index.php?id=106735.
Regulation G: GAAP and Non-GAAP Financial Information
This release contains certain financial information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this release in the tables which follow.
About RadNet, Inc.
RadNet, Inc. is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of 251 fully-owned and operated outpatient imaging centers. RadNet's core markets include California, Maryland, Delaware, Rhode Island, New Jersey and New York. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 6,300 employees. For more information, visit http://www.radnet.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning successfully integrating acquired operations, successfully achieving 2013 financial guidance, achieving cost savings, successfully developing and integrating new lines of business, continuing to grow its business by generating patient referrals and contracts with radiology practices, and receiving third-party reimbursement for diagnostic imaging services, are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause the Company's actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect RadNet's business and its financial results are detailed in its most recent Annual Report on Form 10-K, as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. RadNet undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
|RADNET, INC. AND SUBSIDIARIES|
|CONDENSED CONSOLIDATED BALANCE SHEETS|
|(IN THOUSANDS EXCEPT SHARE DATA)|
|September 30,||December 31,|
|Cash and cash equivalents||$ 268||$ 362|
|Accounts receivable, net||134,265||129,194|
|Current portion of deferred tax assets||5,888||7,607|
|Prepaid expenses and other current assets||17,803||18,737|
|Total current assets||158,224||155,900|
|PROPERTY AND EQUIPMENT, NET||217,383||216,560|
|Other intangible assets||50,808||51,674|
|Deferred financing costs||10,600||11,977|
|Investment in joint ventures||28,610||28,598|
|Deferred tax assets, net of current portion||49,679||48,535|
|Deposits and other||3,738||3,749|
|Total assets||$ 715,132||$ 710,864|
|LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)|
|Accounts payable, accrued expenses and other||$ 99,765||$ 106,357|
|Due to affiliates||1,273||1,602|
|Current portion of deferred rent||1,448||1,164|
|Current portion of notes payable||5,431||4,703|
|Current portion of obligations under capital leases||2,071||3,942|
|Total current liabilities||111,436||119,041|
|Deferred rent, net of current portion||18,459||15,850|
|Line of credit||3,400||33,000|
|Notes payable, net of current portion||571,082||537,009|
|Obligations under capital lease, net of current portion||2,523||3,753|
|Other non-current liabilities||7,870||8,895|
|STOCKHOLDERS' EQUITY (DEFICIT)|
|Common stock - $.0001 par value, 200,000,000 shares authorized; 40,089,196, and 38,540,482 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively||4||4|
|Accumulated other comprehensive (loss) income||(65)||39|
|Total RadNet, Inc.'s stockholders' equity (deficit)||(1,830)||(7,318)|
|Total stockholders' equity (deficit)||362||(6,684)|
|Total liabilities and stockholders' equity (deficit)||$ 715,132||$ 710,864|
Balance Sheet Note
Per RadNet's 8-K filed on November 8, 2013, the above Balance Sheet reflects the restatement of certain accounts. On November 6, 2013, the Audit Committee of the Board of Directors of RadNet, Inc. (the "Company"), based on the recommendation of management, and after discussion with the Company's independent registered public accounting firm, Ernst & Young LLP, determined that the Company's consolidated financial statements for the fiscal year ended December 31, 2012 and Ernst & Young LLP's reports thereon (including Ernst & Young LLP's report on the effectiveness of internal control over financial reporting), should no longer be relied upon because of the impact of an overstatement of deferred tax assets.
In the fourth quarter of 2012, the Company recorded a benefit from income taxes of approximately $60.4 million primarily related to releasing a valuation allowance against its deferred tax assets. In November 2013, during a review of the Company's work papers supporting its deferred tax assets, management discovered an error in the historical tax treatment of certain mark-to-market adjustments recorded in relation to its interest rate swaps, dating back as far as 2009. This error caused the Company's deferred tax assets to be overstated by approximately $4.3 million and unrecognized tax benefit liability (included in accounts payable, accrued expenses and other) to be understated by approximately $0.4 million at December 31, 2012. Periods prior to the fourth quarter of 2012 were not significantly impacted by the overstatement as the Company had a valuation allowance established against the overstated deferred tax assets.
To correct the overstatement of the income tax benefit described above, the Company intends to amend its Annual Report on Form 10-K for the year ended December 31, 2012 originally filed with the SEC on March 18, 2013 and amended on April 1, 2013.
The restatement changed the following line items in the Company's December 31, 2012 balance sheet:
|As of December 31, 2012|
|Current portion of deferred tax assets||$ 7,607||$ 7,607|
|Deferred tax assets, net of current portion||52,790||48,535|
|Total deferred tax assets||60,397||56,142|
|Accounts payable, accrued expenses and other||105,929||106,357|
|RADNET, INC. AND SUBSIDIARIES|
|CONDENSED CONSOLIDATED STATEMENTS OF OPERATION|
|(IN THOUSANDS EXCEPT SHARE DATA)|
|Three Months Ended||Nine Months Ended|
|September 30,||September 30,|
|Service fee revenue, net of contractual allowances and discounts||$ 165,373||$ 152,381||$ 496,424||$ 463,733|
|Provision for bad debts||(7,033)||(6,574)||(20,810)||(19,453)|
|Net service fee revenue||158,340||145,807||475,614||444,280|
|Revenue under capitation arrangements||16,848||14,646||49,034||43,540|
|Total net revenue||175,188||160,453||524,648||487,820|
|Cost of operations, excluding depreciation and amortization||151,770||133,223||450,030||405,177|
|Depreciation and amortization||14,762||13,369||44,050||43,154|
|(Gain) loss on sale and disposal of equipment||(5)||(45)||357||255|
|Total operating expenses||166,599||146,613||494,749||449,264|
|INCOME FROM OPERATIONS||8,589||13,840||29,899||38,556|
|Equity in earnings of joint ventures||(1,617)||(909)||(4,481)||(4,157)|
|Gain on sale of imaging centers||--||--||(2,108)||--|
|Gain on de-consolidation of joint venture||(2,777)||--||(2,777)|
|Other expense (income)||4||(1,360)||152||(3,851)|
|Total other expenses||9,439||8,829||28,105||30,132|
|(LOSS) INCOME BEFORE INCOME TAXES||(850)||5,011||1,794||8,424|
|Provision for income taxes||483||(30)||(766)||(696)|
|NET (LOSS) INCOME||(367)||4,981||1,028||7,728|
|Net income (loss) attributable to noncontrolling interests||100||(72)||151||(160)|
|NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC.|
|COMMON STOCKHOLDERS||$ (467)||$ 5,053||$ 877||$ 7,888|
|BASIC NET (LOSS) INCOME PER SHARE|
|ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS||$ (0.01)||$ 0.13||$ 0.02||$ 0.21|
|DILUTED NET (LOSS) INCOME PER SHARE|
|ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS||$ (0.01)||$ 0.13||$ 0.02||$ 0.20|
|WEIGHTED AVERAGE SHARES OUTSTANDING|
|RADNET, INC. AND SUBSIDIARIES|
|CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (IN THOUSANDS)|
|Nine Months Ended|
|CASH FLOWS FROM OPERATING ACTIVITIES|
|Net income||$ 1,028||$ 7,728|
|Adjustments to reconcile net income to net cash provided by operating activities:|
|Depreciation and amortization||44,050||43,154|
|Provision for bad debt||20,810||19,453|
|Equity in earnings of joint ventures||(4,481)||(4,157)|
|Distributions from joint ventures||5,624||5,526|
|Deferred rent amortization||2,893||2,990|
|Amortization of deferred financing cost||1,676||1,803|
|Amortization of bond and term loan discount||1,651||706|
|Loss on sale and disposal of equipment||357||255|
|Gain on sale of imaging centers||(2,108)||--|
|Gain on de-consolidation of joint venture||--||(2,777)|
|Amortization of cash flow hedge||--||827|
|Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:|
|Other current assets||(1,504)||(433)|
|Accounts payable, accrued expenses and other||(5,357)||(3,255)|
|Net cash provided by operating activities||42,510||55,618|
|CASH FLOWS FROM INVESTING ACTIVITIES|
|Purchase of imaging facilities||(5,918)||(10,617)|
|Purchase of property and equipment||(39,921)||(35,279)|
|Proceeds from sale of equipment||510||841|
|Proceeds from sale of imaging facilities||3,920||2,300|
|Proceeds from sale of joint venture interests||2,640||1,800|
|Purchase of equity interest in joint ventures||(1,803)||(2,756)|
|Net cash used in investing activities||(40,572)||(43,711)|
|CASH FLOWS FROM FINANCING ACTIVITIES|
|Principal payments on notes and leases payable||(7,476)||(11,180)|
|Deferred financing costs||(432)||--|
|Proceeds from borrowings upon refinancing||35,122||--|
|Net (payments on) proceeds from line of credit||(29,600)||1,800|
|Payments to counterparties of interest rate swaps, net of amounts received||--||(4,587)|
|Distributions to noncontrolling interests||(11)||(67)|
|Proceeds from issuance of common stock upon exercise of options/warrants||469||--|
|Net cash used in financing activities||(1,928)||(14,034)|
|EFFECT OF EXCHANGE RATE CHANGES ON CASH||(104)||60|
|NET DECREASE IN CASH AND CASH EQUIVALENTS||(94)||(2,067)|
|CASH AND CASH EQUIVALENTS, beginning of period||362||2,455|
|CASH AND CASH EQUIVALENTS, end of period||$ 268||$ 388|
|SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION|
|Cash paid during the period for interest||$ 26,614||$ 32,074|
|RECONCILIATION OF GAAP NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS TO ADJUSTED EBITDA(1)|
|Three Months Ended|
|Net Income (Loss) Attributable to RadNet, Inc. Common Shareholders||$ (467)||$ 5,053|
|Plus Provision for (Benefit from) Income Taxes||(483)||30|
|Plus Other Expenses (Income)||4||(1,360)|
|Plus Interest Expense||11,052||13,875|
|Plus Severence Costs||72||66|
|Plus Loss (Gain) on Sale of Equipment||(5)||(45)|
|Plus Depreciation and Amortization||14,762||13,369|
|Less Gain on Sale of JV||--||(2,777)|
|Plus Non Cash Employee Stock Compensation||463||433|
|Adjusted EBITDA(1)||$ 25,398||$ 28,644|
|Nine Months Ended|
|Net Income Attributable to RadNet, Inc. Common Shareholders||$ 877||$ 7,888|
|Plus Provision for Income Taxes||766||696|
|Plus Other Expenses (Income)||152||(3,851)|
|Plus Interest Expense||34,542||40,917|
|Plus Severence Costs||312||678|
|Plus Loss (Gain) on Sale of Equipment||357||255|
|Plus Loss (Gain) on Sale of Imaging Centers||(2,108)||--|
|Plus Depreciation and Amortization||44,050||43,154|
|Plus Non Cash Employee Stock Compensation||2,045||2,139|
|Less Gain on Sale of JV||--||(2,777)|
|Adjusted EBITDA(1)||$ 80,993||$ 89,099|
|PAYOR CLASS BREAKDOWN**|
|Workers Compensation/Personal Injury||4.8%|
|**Capitation percentage has been calculated based upon its proportion of cash received in the period to total accrued revenue.|
|After deducting the capitation percentage from 100%, all other payor class percentages are based upon a proportion to global payments received from consolidated imaging centers from that periods dates of services and excludes payments from hospital contracts, Breastlink, imaging center management fees, eRAD, Imaging on Call and other miscellaneous revenue.|
|RADNET PAYMENTS BY MODALITY *|
|Third Quarter||Full Year||Full Year|
|* Based upon global payments received from consolidated Imaging Centers from that periods dates of service.|
|Excludes payments from hospital contracts, Breastlink, Center Management Fees and other miscellaneous operating activities.|
(1) The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and adjusted for losses or gains on the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events that have taken place during the period.
Adjusted EBITDA is reconciled to its nearest comparable GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by RadNet management and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.
(2) As noted above, the Company defines Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest paid. Free Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow because the Company believes it provides useful information for investors and management because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not represent total cash flow since it does not include the cash flows generated by or used in financing activities. In addition, our definition of Free Cash Flow may differ from definitions used by other companies.
Free Cash Flow should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.
CONTACT: RadNet, Inc. Mark Stolper, 310-445-2800 Executive Vice President and Chief Financial Officer